thymidine monophosphate has been researched along with HIV Coinfection in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (58.33) | 29.6817 |
| 2010's | 2 (16.67) | 24.3611 |
| 2020's | 3 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, F; Wang, HL | 1 |
| Desoubeaux, G; Ehrmann, S; Lemaignen, A | 2 |
| Barbás, MG; Bissio, E; Bouzas, MB; Cudolá, A; Espínola, L; Falistocco, C; Fernández Giuliano, S; Kademián, S; Mammana, L; Ornani, ML; Ravasi, G; Salomón, H; Vila, M; Zapiola, I | 1 |
| Cahn, P; D'Cruz, O; Qazi, S; Uckun, FM | 1 |
| Chen, CL; Lisowski, E; Pendergrass, S; Qazi, S; Uckun, FM; Venkatachalam, TK; Waurzyniak, B | 1 |
| Pendergrass, S; Qazi, S; Richman, D; Uckun, FM; Venkatachalam, TK | 1 |
| Pendergrass, S; Qazi, S; Uckun, FM; Venkatachalam, TK | 1 |
| Uckun, FM | 2 |
| D'Cruz, OJ; Uckun, FM | 2 |
4 review(s) available for thymidine monophosphate and HIV Coinfection
| Article | Year |
|---|---|
Stampidine as a promising antiretroviral drug candidate for pre-exposure prophylaxis against sexually transmitted HIV/AIDS.
Topics: Animals; Anti-Retroviral Agents; Clinical Trials, Phase I as Topic; Clinical Trials, Phase III as Topic; Dideoxynucleotides; Drug Evaluation, Preclinical; HIV Infections; HIV-1; Humans; Randomized Controlled Trials as Topic; Stavudine; Thymidine Monophosphate | 2012 |
Unmet challenges in HIV therapy and potential of stampidine.
Topics: Animals; Anti-HIV Agents; Dideoxynucleotides; HIV Infections; Humans; Reverse Transcriptase Inhibitors; Stavudine; Thymidine Monophosphate | 2006 |
Stampidine as a novel nucleoside reverse transcriptase inhibit with potent anti-HIV activity.
Topics: Anti-HIV Agents; Chemistry, Pharmaceutical; Dideoxynucleotides; Drug Resistance, Viral; HIV Infections; HIV-1; Humans; Liver; Reverse Transcriptase Inhibitors; Stavudine; Thymidine Monophosphate | 2006 |
Microbicides for multidrug-resistant and multitropic HIV-1.
Topics: Animals; Anti-HIV Agents; Anti-Infective Agents; Dideoxynucleotides; Drug Resistance, Multiple, Viral; Drug Therapy, Combination; HIV Infections; HIV-1; Humans; Pyridines; Stavudine; Thiourea; Thymidine Monophosphate | 2008 |
8 other study(ies) available for thymidine monophosphate and HIV Coinfection
| Article | Year |
|---|---|
Reply to: Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future.
Topics: Caspofungin; Glucans; HIV Infections; Humans; Pneumocystis carinii; Pneumonia, Pneumocystis; Thymidine Monophosphate | 2020 |
Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future….
Topics: Caspofungin; Glucans; HIV Infections; Humans; Pneumocystis carinii; Pneumonia, Pneumocystis; Thymidine Monophosphate | 2020 |
Reply to the reply to Scientific rationale for inhaled caspofungin to treat Pneumocystis pneumonia: A therapeutic innovation likely relevant to investigate in a near future ….
Topics: Caspofungin; Glucans; HIV Infections; Humans; Pneumocystis carinii; Pneumonia, Pneumocystis; Thymidine Monophosphate | 2020 |
Pretreatment HIV-1 drug resistance in Argentina: results from a surveillance study performed according to WHO-proposed new methodology in 2014-15.
Topics: Adult; Anti-HIV Agents; Argentina; CD4 Lymphocyte Count; Cross-Sectional Studies; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Male; Reverse Transcriptase Inhibitors; Thymidine Monophosphate | 2017 |
In vivo toxicity, pharmacokinetics, and anti-human immunodeficiency virus activity of stavudine-5'-(p-bromophenyl methoxyalaninyl phosphate) (stampidine) in mice.
Topics: Administration, Oral; Animals; Anti-HIV Agents; Biotransformation; Chromatography, High Pressure Liquid; Dideoxynucleotides; Drug Resistance, Viral; Female; HIV Infections; HIV-1; Humans; Injections, Intraperitoneal; Mice; Mice, Inbred BALB C; Mice, SCID; Stavudine; Thymidine Monophosphate | 2002 |
Stampidine is a potent inhibitor of Zidovudine- and nucleoside analog reverse transcriptase inhibitor-resistant primary clinical human immunodeficiency virus type 1 isolates with thymidine analog mutations.
Topics: Anti-HIV Agents; Dideoxynucleotides; Drug Resistance, Viral; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Nucleosides; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Structure-Activity Relationship; Thymidine; Thymidine Monophosphate; Zidovudine | 2002 |
In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates.
Topics: Cells, Cultured; Dideoxynucleotides; Drug Resistance, Viral; Genotype; HIV; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Neutrophils; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Thymidine Monophosphate; Viral Plaque Assay; Zidovudine | 2004 |
Mucosal safety of PHI-443 and stampidine as a combination microbicide to prevent genital transmission of HIV-1.
Topics: Administration, Intravaginal; Animals; Anti-Infective Agents, Local; Dideoxynucleotides; Drug Therapy, Combination; Female; HIV Infections; HIV-1; Humans; Mucous Membrane; Pyridines; Rabbits; Stavudine; Thiourea; Thymidine Monophosphate; Vagina | 2007 |